|
Sanofi India Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
8888.67 Cr.
|
P/BV
|
11.59
|
Book Value (Rs.)
|
332.96
|
|
52 Week High/Low (Rs.)
|
6717/3843
|
FV/ML
|
10/1
|
P/E(X)
|
27.21
|
|
Bookclosure
|
07/11/2025
|
EPS (Rs.)
|
141.85
|
Div Yield (%)
|
1.94
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR |
| FaceValue | 10.00 | 10.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 2013.20 | 2817.50 |
| Other Operating Revenues | 0.00 | 33.60 |
| Total Operating Revenues | 2013.20 | 2851.10 |
| | | |
| Other Income | 16.50 | 65.30 |
| Total Revenue | 2029.70 | 2916.40 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 354.80 | 564.40 |
| Purchase Of Stock-In Trade | 564.30 | 929.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 60.20 | -292.40 |
| Employee Benefit Expenses | 240.20 | 370.60 |
| Finance Costs | 1.50 | 1.70 |
| Depreciation And Amortisation Expenses | 36.70 | 39.60 |
| Other Expenses | 302.90 | 475.80 |
| Total Expenses | 1560.60 | 2088.70 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 469.10 | 827.70 |
| | | |
| Exceptional Items | -37.70 | 17.80 |
| Profit/Loss Before Tax | 431.40 | 845.50 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 117.70 | 243.30 |
| Deferred Tax | 0.00 | -0.70 |
| Total Tax Expenses | 117.70 | 242.60 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 313.70 | 602.90 |
| | | |
| Extraordinary Items | 99.60 | 0.00 |
| Profit/Loss From Continuing Operations | 413.30 | 602.90 |
| | | |
| Profit/Loss For The Period | 413.30 | 602.90 |
| Consolidated Profit/Loss After MI And Associates | 413.30 | 602.90 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | 179.46 | 261.78 |
| Diluted EPS (Rs.) | 179.46 | 261.78 |
| | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | |
| Equity Share Dividend | 0.00 | 843.20 |
